Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/14/2025

Acute Asthma Exacerbation Management

Introduction to Heliox Use

  • Heliox, a mixture of helium and oxygen, is not recommended for routine use in acute asthma exacerbations due to insufficient evidence supporting its routine use, as stated by the American Thoracic Society and British Thoracic Society 1

Indications and Contraindications for Heliox Use

  • Heliox may be considered in clinical trials or by specialists for severe asthma exacerbations that are not responding to standard treatment, with the strongest evidence for its benefit existing in cases of mechanical upper airway obstruction or postoperative stridor, according to the British Thoracic Society 1
  • Heliox is not recommended for routine use in mild to moderate asthma exacerbations, routine COPD exacerbations, or as a driving gas for nebulizer therapy outside of specialized settings, due to insufficient evidence and high cost 1

Efficacy and Outcomes of Heliox Use

  • The British Thoracic Society (BTS) and Intensive Care Society (ICS) guidelines state that heliox does not reduce rates of intubation, length of IMV, or mortality in patients with AECOPD or asthma (Level 1+) 2
  • Heliox does not have a significant benefit over air-oxygen mixtures in asthma or COPD, and its use is limited by high cost (evidence level 1−) 1
  • Meta-analyses have concluded that heliox does not affect outcomes in asthma 2
  • Even in severe exacerbations, heliox has not been shown to reduce mortality or need for mechanical ventilation 2, 1

Mechanism of Action and Physiological Effects

  • Heliox reduces resistance to airflow in narrowed airways and decreases work of breathing in obstructive conditions, but these benefits have not translated to mortality benefits in clinical trials 2
  • Heliox may improve delivery of nebulized medications, but its use does not affect outcomes in asthma 2

Limitations and Cost-Effectiveness of Heliox Use

  • Higher cost compared to standard oxygen-air mixtures limits the routine use of heliox 1
  • At oxygen concentrations >40%, heliox loses its theoretical advantages 2
  • The British Thoracic Society (BTS) guidelines recommend heliox use only in clinical trials or exceptional circumstances for most patients with acute exacerbations of asthma or COPD, due to its high cost and limited benefit (Grade D) 1